Algernon Pharmaceuticals Inc.

AGN on CSEToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
0.29CAN 0.02/5.56%164,9250.10 / 0.5513.35 M
BTHCF on OTCQBToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
0.21US -0.00/-0.90%61,3750.07 / 0.409.84 M

Contact Information

Algernon Pharmaceuticals Inc.

Headquarters:
700 West Pender Street, Suite 915
Vancouver, British Columbia
Canada, V6C 1G8
Tel: 604-646-1553
Email: Send a message
Website: Visit website
For more information...
Lead: Barry Mire
Apr 23, 2019 - 12:00 PM EDT Corporate Presentation - New York
Apr 24, 2019 - 12:00 PM CDT Corporate Presentation - Chicago
Apr 25, 2019 - 12:00 PM CDT Corporate Presentation - Minneapolis
Apr 29, 2019 - 1:00 PM PDT Corporate Presentation - Vancouver

Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on advancing its lead compounds for of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD).

Christoper J. Moreau - Chief Executive Officer

Mark Williams, PhD, MBA - Chief Science Officer

Michael Sadhra, CA - Chief Financial Officer & Director

Raj Attariwala, MD, PhD. - Director

Michael Sadhra, CA - Chief Financial Officer & Director

David Levina - Director

Stock Information

Events

Apr 23, 2019 - 12:00 PM EDT Corporate Presentation - New York
Apr 24, 2019 - 12:00 PM CDT Corporate Presentation - Chicago
Apr 25, 2019 - 12:00 PM CDT Corporate Presentation - Minneapolis
Apr 29, 2019 - 1:00 PM PDT Corporate Presentation - Vancouver

Company Overview

Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on advancing its lead compounds for of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD).

Management

Christoper J. Moreau - Chief Executive Officer

Mark Williams, PhD, MBA - Chief Science Officer

Michael Sadhra, CA - Chief Financial Officer & Director

Board of Directors

Raj Attariwala, MD, PhD. - Director

Michael Sadhra, CA - Chief Financial Officer & Director

David Levina - Director

Contact Information

Headquarters:
700 West Pender Street, Suite 915
Vancouver, British Columbia
V6C 1G8, Canada
Telephone: 604-646-1553
Email: Send a message
Website: Visit website